Nathalie Wauthoz

Nathalie Wauthoz is a co-founder and scientific advisor of inhatarget-therapeutics, based in Brussels. Her stated areas of expertise are dry powder inhalers, lung cancer, glioblastoma, nose to brain delivery and controlled release.

She has been an associate professor at the Université libre de Bruxelles since October 2017, having previously been a postdoctoral researcher there from January 2013 to September 2017. Before that, she spent 2012 as a postdoctoral research fellow at UMR Inserm 1066.

Wauthoz studied pharmaceutical sciences at the Université libre de Bruxelles from 2001 to 2006 and went on to complete a PhD in biomedical and pharmaceutical sciences there, in pharmacy, between 2006 and 2011.